All Posts Tagged With: "Access to Medicine"
Glaxo Smith Kline Access to Medicine PDF
Access to Medicines (PDF) - GSK
Excerpt: We will continue to research and develop medicines to treat diseases of the developing world. We will find sustainable ways to improve access to medicines for disadvantaged people, and will seek partnerships to support this activity.
Novartis Four Pillars - Patients & Access to Medicine
Novartis Patients Access to Medicine - Novartis
Excerpt: Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. In 2007 our access-to-medicines programs, valued at USD 937 million, reached 66 million patients globally. In the developing world, we extend free leprosy and tuberculosis treatment and offer our antimalarial drug Coartem without profit through multilateral institutions and public-private partnerships.
Access to Medicine - Corporate Responsibility Review 2006
Access to Medicines - GSK
Excerpt: We have a Corporate Responsibility Committee of non-executive board directors which provides high-level guidance on our approach to CR. The CEO and members of the corporate executive team are actively inovlved in CR and participate in the CRC meetings.
Access to Medicine at Citizenship@Novartis
Access to Medicines - Novartis
Excerpt: The issue of access to medicines is complex, involving factors such as development and health policies, health system infrastructure and best practices, pricing, rational use of drugs and adequate funding.
Sanofi-Aventis on Access to Medicine
Access to Medicine - Patient Assistance Programs - Sanofi-Aventis
Excerpt: The Partnership for Prescription Assistance brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that’s right for them. Many will get them free or nearly free. Through their website the Partnership for Prescription Assistance offers a single point of access to more than 475 public and private patient assistance programs, including more than 150 programs offered by sanofi-aventis and pharmaceutical companies.
The United States Trade Representative on Access to Medicine
U.S. and Canada Agree to Assist Poor Countries Access to Medicine - USTR, July 2004
Excerpt: SAN ANTONIO, TEXAS – At the annual North American Free Trade Agreement (NAFTA) Commission meeting, the United States today announced a Memorandum of Understanding (MOU) with Canada has been agreed to which ensures that NAFTA will not impede their efforts to assist poor countries from importing generic versions of patented drugs from Canada in response to health crises like HIV-AIDS.
Novartis Access to Medicine PDF
Access to Medicines in the Developing World (PDF) - Novartis, November 2005
Excerpt: According to the World Health Organization (WHO), one third of the world’s population lacks regular access to essential drugs. This estimate rises to over 40% in low-income countries and over 50% in poorest countries of Asia and Africa, where infectious diseases such as tuberculosis, malaria and AIDS are the leading cause of death. Yet, most of these diseases can be prevented or treated. Some leading non-governmental organizations (NGOs) argue that drug prices and patents are the principal obstacle to access and advocate equity pricing, parallel trade and compulsory licensing. In response, the pharmaceutical industry stresses that medicines alone cannot solve the underlying problems of poverty, inadequate public health services or lack of healthcare personnel and infrastructure that beset developing countries and asserts that the protection of intellectual property rights is critical to the development of new medicines. Novartis has been a leader in improving access to medicines through programs supporting our anti malaria treatment Coartem and the Glivec International Patient Assistance Program.
PhRMA President Speaks Out On Access to Medicine
PhRMA CEO Billy Tauzin on Access to Medicine in West Virginia - PhRMA.org
Excerpt: Pharmaceutical companies are working every day to find new cures and treatments for society’s greatest health problems. As a cancer survivor, I understand that there is nothing more precious than your health and the health of loved ones. And I am here to tell you that without prescription medicines, the health of far too many would be in worse shape.